Basiliximab Treating Interstitial Pneumonia of CADM

Clinical trial NCT03192657 · UNKNOWN

Trial details

NCT number: NCT03192657
Sponsor: RenJi Hospital
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Lung; Disease, Interstitial, With Fibrosis Dermatomyositis

Start date: 2017-07-01
Primary completion: 2019-06-01
Enrollment: 100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.